Agile Therapeutics, Inc. (AGRX)

Last Year

05-Feb-22 -- 04-Feb-23

Time Period:

$22.50K Net Amount

Buy:	$22.50K	$0.45
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

15

0

8

+1

0

+2

0

+3

Two Year Chart

05-Feb-21 -- 04-Feb-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
10-Jun-22 4:45 PM View:	09-Jun-22 Grant 0	Tursi James Patrick Director		Agile Therapeutics, Inc. - AGRX	48% 1.4K to 2.07K	0	0	--	--	Show Txns Hide Txns

10-Jun-22 4:47 PM View:	09-Jun-22 Grant 0	Hubbard John W Director		Agile Therapeutics, Inc. - AGRX	48% 1.4K to 2.07K	0	0	--	--	Show Txns Hide Txns

10-Jun-22 4:46 PM View:	09-Jun-22 Grant 0	Shetty Ajit Director		Agile Therapeutics, Inc. - AGRX	43% 1.57K to 2.24K	0	0	--	--	Show Txns Hide Txns

10-Jun-22 4:47 PM View:	09-Jun-22 Grant 0	Fischer Seth H.Z. Director		Agile Therapeutics, Inc. - AGRX	48% 1.4K to 2.07K	0	0	--	--	Show Txns Hide Txns

29-Aug-22 8:30 AM View:	26-Aug-22 Market Purchase $22.50K	Altomari Alfred Chief Executive Officer Director		Agile Therapeutics, Inc. - AGRX	349% 14.34K to 64.34K	$22.50K 349%	0	$0.45	--	Show Txns Hide Txns

10-Jun-22 4:49 PM View:	09-Jun-22 Grant 0	Barbari Sharon Surrey Director		Agile Therapeutics, Inc. - AGRX	52% 1.28K to 1.95K	0	0	--	--	Show Txns Hide Txns

10-Jun-22 4:48 PM View:	09-Jun-22 Grant 0	Carson Sandra Director		Agile Therapeutics, Inc. - AGRX	52% 1.28K to 1.95K	0	0	--	--	Show Txns Hide Txns

10-Jun-22 4:45 PM View:	09-Jun-22 Grant 0	Torrente Josephine Director		Agile Therapeutics, Inc. - AGRX	34% 1.99K to 2.66K	0	0	--	--	Show Txns Hide Txns